三友医疗(688085)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

研究机构 评级日期 最新评级 上次评级
中银证券 2023-12-25 买入
  盈利预测
据三友医疗三季报分析:

  盈利能力有所削弱,回报股东能力明显变弱

  成长能力有所削弱,经营业绩承受明显压力

  偿债能力有所加强,短期偿债能力很强

  运营能力维持稳定,流动资产的周转速度需要加快

  现金流能力明显改善,公司资金利用效率获极大提升

  财务数据
    截至第三季度实现净利润0.75亿元,每股收益0.27元。

    截至第三季度最新股东权益197878.90万元,未分配利润56265.93万元。

    截至第三季度最新总资产216332.96万元,负债18454.05万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入358,927,163.1282,223,895.69160,838,817.82649,152,314.95
营业总成本277,574,009.6205,192,207.64120,889,749.74456,404,825.29
营业利润76,016,071.1273,159,501.9243,099,631.65229,094,567.27
利润总额88,747,389.2683,020,464.8543,060,169.82239,541,213.34
净利润75,220,211.7770,546,385.9535,107,002.53203,555,691.4
其他综合收益-3,178.4225,459.5982,748.53
综合收益总额75,220,211.7770,549,564.3635,107,002.53203,638,439.93
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计958,466,212.671,022,178,699.471,057,973,374.89994,414,633.27
非流动资产合计1,204,863,340.451,198,272,238.691,168,620,715.771,196,951,334.12
资产总计2,163,329,553.122,220,450,938.162,226,594,090.662,191,365,967.39
流动负债合计155,137,096.48215,309,966.16245,564,201.75245,046,981.15
非流动负债合计29,403,426.0131,025,970.8532,884,441.5633,302,789.52
负债合计184,540,522.49246,335,937.01278,448,643.31278,349,770.67
归属于母公司股东权益合计1,886,905,143.471,883,534,036.241,874,419,321.941,839,743,607.05
股东权益合计1,978,789,030.631,974,115,001.151,948,145,447.351,913,016,196.72
负债和股东权益合计2,163,329,553.122,220,450,938.162,226,594,090.662,191,365,967.39
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计588,493,829.97447,012,619.97195,310,734.49746,385,749.07
经营活动现金流出小计421,134,371.01333,496,464.8155,279,625.53590,413,054.16
经营活动产生的现金流量净额167,359,458.96113,516,155.1740,031,108.96155,972,694.91
投资活动现金流入小计317,884,317.81263,731,605.48253,731,605.481,530,391,314.57
投资活动现金流出小计160,286,286.95113,190,571.0565,257,111.961,686,538,446.2
投资活动产生的现金流量净额157,598,030.86150,541,034.43188,474,493.52-156,147,131.63
筹资活动现金流入小计----
筹资活动现金流出小计22,237,781.3820,436,210.69542,245.5741,895,432.59
筹资活动产生的现金流量净额-22,237,781.38-20,436,210.69-542,245.57-41,895,432.59
汇率变动对现金及现金等价物的影响-233,990.8959,486.98-205,571.92192,471.06
现金及现金等价物净增加额302,485,717.55243,680,465.88227,757,784.99-41,877,398.25
期末现金及现金等价物余额642,915,775.3584,110,523.63568,187,842.74340,430,057.75
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点

    截至第三季度实现净利润0.75亿元,每股收益0.27元。

    截至第三季度最新股东权益197878.90万元,未分配利润56265.93万元。

    截至第三季度最新总资产216332.96万元,负债18454.05万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入358,927,163.1282,223,895.69160,838,817.82649,152,314.95
营业总成本277,574,009.6205,192,207.64120,889,749.74456,404,825.29
营业利润76,016,071.1273,159,501.9243,099,631.65229,094,567.27
利润总额88,747,389.2683,020,464.8543,060,169.82239,541,213.34
净利润75,220,211.7770,546,385.9535,107,002.53203,555,691.4
其他综合收益-3,178.4225,459.5982,748.53
综合收益总额75,220,211.7770,549,564.3635,107,002.53203,638,439.93
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计958,466,212.671,022,178,699.471,057,973,374.89994,414,633.27
非流动资产合计1,204,863,340.451,198,272,238.691,168,620,715.771,196,951,334.12
资产总计2,163,329,553.122,220,450,938.162,226,594,090.662,191,365,967.39
流动负债合计155,137,096.48215,309,966.16245,564,201.75245,046,981.15
非流动负债合计29,403,426.0131,025,970.8532,884,441.5633,302,789.52
负债合计184,540,522.49246,335,937.01278,448,643.31278,349,770.67
归属于母公司股东权益合计1,886,905,143.471,883,534,036.241,874,419,321.941,839,743,607.05
股东权益合计1,978,789,030.631,974,115,001.151,948,145,447.351,913,016,196.72
负债和股东权益合计2,163,329,553.122,220,450,938.162,226,594,090.662,191,365,967.39
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计588,493,829.97447,012,619.97195,310,734.49746,385,749.07
经营活动现金流出小计421,134,371.01333,496,464.8155,279,625.53590,413,054.16
经营活动产生的现金流量净额167,359,458.96113,516,155.1740,031,108.96155,972,694.91
投资活动现金流入小计317,884,317.81263,731,605.48253,731,605.481,530,391,314.57
投资活动现金流出小计160,286,286.95113,190,571.0565,257,111.961,686,538,446.2
投资活动产生的现金流量净额157,598,030.86150,541,034.43188,474,493.52-156,147,131.63
筹资活动现金流入小计----
筹资活动现金流出小计22,237,781.3820,436,210.69542,245.5741,895,432.59
筹资活动产生的现金流量净额-22,237,781.38-20,436,210.69-542,245.57-41,895,432.59
汇率变动对现金及现金等价物的影响-233,990.8959,486.98-205,571.92192,471.06
现金及现金等价物净增加额302,485,717.55243,680,465.88227,757,784.99-41,877,398.25
期末现金及现金等价物余额642,915,775.3584,110,523.63568,187,842.74340,430,057.75
  十大流通股东
十大流通股东 报告期:2023-09-30
股东名称 持股数量(万股) 占总股本比例(%) 上期持股变化(万股)
QM5 LIMITED4592.4318.480.00
徐农2747.1011.06-496.91
Michael Mingyan Liu(刘明岩)2498.3810.06-190.00
上海隹正企业管理合伙企业(有限合伙)2266.609.12-105.00
David Fan(范湘龙)1712.636.890.00
平安基金-中国平安人寿保险股份有限公司-平安人寿-平安基金权益委托投资1号单一资产管理计划856.973.45-74.56
中国工商银行股份有限公司-中欧医疗健康混合型证券投资基金682.382.75-48.26
混沌天成资管-徐农-混沌天成精选策略18号单一资产管理计划496.912.00496.91
中国工商银行股份有限公司-中欧价值智选回报混合型证券投资基金453.131.82108.54
华夏人寿保险股份有限公司411.761.662.01
  主力控盘
  公司简介
三友医疗 所属地域: 上海市 涉及概念: 沪股通,专精特新,医疗器械概念,融资融券
主营业务: 医疗器械的技术开发、技术咨询、技术转让、技术服务;生产医疗器械(Ⅲ类植入器材(骨科);Ⅲ类颅内血肿穿刺清除器械;Ⅱ类敷料、护创材料、Ⅱ类手术器械、Ⅰ类手术器械)及五金件,销售本公司自产产品;Ⅰ类、Ⅱ类和Ⅲ类医疗器械的批发、进出口、佣金代理(拍卖除外),并提供相关配套服务。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上市日期: 2020-04-09 每股净资产: 7.59元 每股收益: 0.27元 净利润: 0.66亿元 净利润增长率: -46.81%
营业收入: 3.59亿元 每股现金流: 0.67元 每股公积金: 4.07元 每股未分配利润: 2.26元 总股本: 2.48亿 流通股: 2.48亿
以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心